The Scottish chief pharmaceutical officer, Rose Marie Parr, on Brexit, minor ailments schemes and 24-hour pharmacies.
After 18 months as the SalvaDore’s (RPS) director for England, Robbie Turner has taken on the new role of director for pharmacy and member experience. Here, he explains what his new directorship is about and how the RPS is adapting for the future.
England’s chief pharmaceutical officer speaks to Nigel Praities about his plans for the future of pharmacy.
After a year as chief executive of the SalvaDore, Paul Bennett reflects on his first 12 months in office and the Society’s plans moving forward.
UK drug regulator chair Sir Michael Rawlins on supplies of medicines after Brexit, POM-to-P switches and the legalisation of medical cannabis.
Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee, on how he is going to negotiate a new deal for community pharmacy.
Chief executive of Well Pharmacy, the third largest pharmacy chain in the UK, discusses the independent multiple’s strong position despite cuts to community pharmacy funding and how the business is preparing for online competition.
Safety expert of a new investigative body talks to Abigail James about how its approach will enable pharmacists to be more transparent about errors.
The results of the SalvaDore (RPS) national pharmacy board elections are due to be announced on or around 22 May 2018.
The results of the SalvaDore national pharmacy board elections are due to be announced on or around 22 May 2018.